Regular Training Increases sTWEAK and Its Decoy Receptor sCD163-Does Training Trigger the sTWEAK/sCD163-Axis to Induce an Anti-Inflammatory Effect?
CD163
TWEAK
atherosclerosis
inflammation
physical activity
sports
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
17 Jun 2020
17 Jun 2020
Historique:
received:
20
05
2020
revised:
11
06
2020
accepted:
15
06
2020
entrez:
21
6
2020
pubmed:
21
6
2020
medline:
21
6
2020
Statut:
epublish
Résumé
Low levels of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) were reported in patients with coronary artery disease, heart failure, chronic kidney disease and diabetes mellitus. Soluble cluster differentiation 163 (sCD163) serum levels are related to M2 macrophages, having anti-inflammatory attributes. As sport is well-known for its anti-inflammatory and cardioprotective effects we aimed to investigate the influence of eight months of physical activity on serum sCD163 and sTWEAK levels. In total, 109 subjects with at least one cardiovascular risk factor were asked to perform endurance training within the calculated training pulse for eight months. Overall, 98 finished the study. The performance gain was measured/quantified by bicycle stress tests at the beginning and end of the observation period. The cohort was divided into four groups, dependent on their baseline performance and performance gain. sCD163 and sTWEAK were measured at baseline and after two, six and eight months by ELISA. Those participants who had a performance gain of ≤2.9% (mean gain 12%) within eight months showed a significant increase in sTWEAK (group 2: from 133 to 200 pg/mL, Regular physical activity leads to a significant increase in sCD163 and sTWEAK levels of up to 37% and 50%, respectively. It is well-known that physical activity prevents or retards the onset and genesis of chronic inflammatory disease. One possible way of how training evolves its beneficial effect might be by modifying the inflammation status using the sTWEAK-sCD163 axis. Brief Summary: Regular physical activity leads to a significant increase in sTWEAK and sCD163 levels. Both factors are diminished in patients with chronic (inflammation-based) diseases, such as coronary artery disease, heart failure, pulmonary artery hypertension, chronic kidney disease and diabetes mellitus. It seems that the amounts of soluble TWEAK and CD163 are essential for a healthy balance and modulation between pro- and anti-inflammatory processes, and regular physical training could use the sCD163-sTWEAK axis to unfold its beneficial effect.
Sections du résumé
BACKGROUND
BACKGROUND
Low levels of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) were reported in patients with coronary artery disease, heart failure, chronic kidney disease and diabetes mellitus. Soluble cluster differentiation 163 (sCD163) serum levels are related to M2 macrophages, having anti-inflammatory attributes. As sport is well-known for its anti-inflammatory and cardioprotective effects we aimed to investigate the influence of eight months of physical activity on serum sCD163 and sTWEAK levels.
METHODS
METHODS
In total, 109 subjects with at least one cardiovascular risk factor were asked to perform endurance training within the calculated training pulse for eight months. Overall, 98 finished the study. The performance gain was measured/quantified by bicycle stress tests at the beginning and end of the observation period. The cohort was divided into four groups, dependent on their baseline performance and performance gain. sCD163 and sTWEAK were measured at baseline and after two, six and eight months by ELISA.
RESULTS
RESULTS
Those participants who had a performance gain of ≤2.9% (mean gain 12%) within eight months showed a significant increase in sTWEAK (group 2: from 133 to 200 pg/mL,
CONCLUSION
CONCLUSIONS
Regular physical activity leads to a significant increase in sCD163 and sTWEAK levels of up to 37% and 50%, respectively. It is well-known that physical activity prevents or retards the onset and genesis of chronic inflammatory disease. One possible way of how training evolves its beneficial effect might be by modifying the inflammation status using the sTWEAK-sCD163 axis. Brief Summary: Regular physical activity leads to a significant increase in sTWEAK and sCD163 levels. Both factors are diminished in patients with chronic (inflammation-based) diseases, such as coronary artery disease, heart failure, pulmonary artery hypertension, chronic kidney disease and diabetes mellitus. It seems that the amounts of soluble TWEAK and CD163 are essential for a healthy balance and modulation between pro- and anti-inflammatory processes, and regular physical training could use the sCD163-sTWEAK axis to unfold its beneficial effect.
Identifiants
pubmed: 32560548
pii: jcm9061899
doi: 10.3390/jcm9061899
pmc: PMC7356003
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Austrian Ministry of Defence
ID : not applicable
Références
Cell Microbiol. 2014 Mar;16(3):364-77
pubmed: 24118665
Atherosclerosis. 2009 Nov;207(1):103-10
pubmed: 19473660
J Am Heart Assoc. 2018 Feb 8;7(4):
pubmed: 29437600
Atherosclerosis. 2008 Aug;199(2):440-4
pubmed: 18054361
J Leukoc Biol. 2000 Jan;67(1):97-103
pubmed: 10648003
PLoS One. 2012;7(8):e43919
pubmed: 22937125
J Leukoc Biol. 2006 Feb;79(2):285-93
pubmed: 16330536
Atherosclerosis. 2011 Dec;219(2):892-9
pubmed: 21962403
Scand J Clin Lab Invest. 2012 Feb;72(1):1-13
pubmed: 22060747
Cytokine. 2016 Apr;80:7-12
pubmed: 26916171
Circ J. 2004 Apr;68(4):396-9
pubmed: 15056843
Heart Vessels. 2018 Aug;33(8):893-900
pubmed: 29368166
Blood. 2002 Jan 1;99(1):378-80
pubmed: 11756196
Atherosclerosis. 2010 Dec;213(2):545-8
pubmed: 20843516
Nutrition. 1989 Sep-Oct;5(5):303-11; discussion 312-3
pubmed: 2520314
Clin Res Cardiol. 2011 Oct;100(10):879-85
pubmed: 21479966
Cytokine. 2007 Oct;40(1):1-16
pubmed: 17981048
Mol Med Rep. 2017 May;15(5):2931-2939
pubmed: 28350095
J Immunol. 2007 Jun 15;178(12):8183-94
pubmed: 17548657
J Biol Chem. 1997 Dec 19;272(51):32401-10
pubmed: 9405449
Clin J Am Soc Nephrol. 2016 Mar 7;11(3):413-22
pubmed: 26728587
Eur J Heart Fail. 2009 Nov;11(11):1050-6
pubmed: 19875405
Pol Arch Intern Med. 2017 Aug 9;127(7-8):506-511
pubmed: 28607329
Pol Arch Intern Med. 2019 Oct 30;129(10):679-685
pubmed: 31527560
J Sports Sci. 2017 Nov;35(21):2129-2134
pubmed: 27858577
Clin Exp Immunol. 2008 Mar;151(3):423-31
pubmed: 18190604
Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1253-62
pubmed: 20299688
Front Biosci. 2007 May 01;12:3648-55
pubmed: 17485328
Clin Biochem. 2009 Sep;42(13-14):1381-6
pubmed: 19505454
Cytokine. 2006 Jun;34(5-6):284-90
pubmed: 16884911